Candida glabrata is a haploid yeast closely related to Saccharomyces cerevisiae (baker's yeast) and is an opportunistic pathogen . It is the second most common cause of systemic candidiasis in adults globally . C. glabrata can persist on surfaces for extended periods and quickly adapt to external stressors, making it resilient to antifungal treatments .
Transformants initially retain the original mtDNA, even under selective pressure. The transformed mtDNA is selectively lost under aerobic conditions. The ratio of original to transformed mtDNA varies based on growth conditions. Cells lacking ATP6 produce more reactive oxygen species (ROS), influencing heteroplasmy dynamics .
| Condition | Effect on mtDNA |
|---|---|
| Arginine Selection | Original mtDNA not spontaneously lost |
| Aerobic Conditions | Selective loss of transformed mtDNA |
| Anaerobic Conditions | Favors loss of original mtDNA |
| Increased ROS | Influences heteroplasmy dynamics in ATP6 deficient cells |
Mitochondrial dysfunction can increase resistance to azoles and ER stress. Deletion of CgMIP1, the mitochondrial DNA polymerase, leads to loss of mitochondrial function and increased resistance to azoles. This phenotype is also induced by fluconazole and macrophage exposure, indicating cross-resistance between antifungals and immune cells .
Perturbing mitochondrial function in Candida albicans reduces susceptibility to xenobiotics by altering efflux. Transcriptional repression of genes involved in mitochondrial function can block filamentous growth in response to Hsp90 inhibitors. Deletion of mitochondrial genes like MSU1 and SHY1 enhances cellular efflux and reduces susceptibility to various compounds .
Yor1 and Cdr1 are key ABC transporters involved in the efflux of geldanamycin and radicicol, respectively. Dysregulation of mitochondria can lead to enhanced efflux pump activity, highlighting the interplay between mitochondrial function and drug resistance mechanisms .
C. glabrata possesses several virulence factors that contribute to its pathogenicity. The multidrug transporter CgDtr1 protects cells from stress agents in macrophages. Deletion of CgDTR1 increases larvae survival upon infection, reducing the killing ability of C. glabrata cells .
C. glabrata cells lacking CgDtr1 show decreased proliferation in Galleria mellonella hemolymph. Overexpression of CgDTR1 leads to increased cell proliferation within hemocytes, indicating its role in intracellular survival .
| Feature | Wild-Type C. glabrata | Δ cgdtr1 Mutant |
|---|---|---|
| Larvae Survival | Lower | Higher |
| Proliferation in Hemolymph | Higher | Lower |
| Proliferation within Hemocytes | Higher | Lower |
| Killing Ability | Higher | Lower |
KEGG: cgr:CAGL0L05698g
AIM23 in Candida glabrata functions as a mitochondrial translation initiation factor 3 (mIF3), similar to its homolog in Saccharomyces cerevisiae. It plays a critical role in the initiation of mitochondrial protein synthesis by promoting the dissociation of mitochondrial ribosomes and facilitating the binding of initiator tRNA. Research has demonstrated that AIM23 is essential for proper mitochondrial function, particularly for oxidative phosphorylation and cellular respiration .
In yeast species, deletion of AIM23 results in a respiratory deficient phenotype characterized by:
Decreased cytochrome c oxidase activity (less than 10% of wild-type levels before adaptation)
Impaired formation of respiratory chain supercomplexes
Reduced mitochondrial membrane potential
Growth defects on non-fermentable carbon sources
Key observations in Δaim23 strains include:
While AIM23 serves as mitochondrial translation initiation factor 3 (mIF3) in both species, there are notable differences in how C. glabrata and S. cerevisiae respond to its deletion:
| Parameter | C. glabrata Δaim23 | S. cerevisiae Δaim23 |
|---|---|---|
| Adaptation to respiratory growth | Shows slow adaptation with gradual increase in cytochrome c oxidase activity | Similar respiratory deficiency but with distinct adaptation patterns |
| Virulence impact | May affect pathogenicity in host environments | Not a pathogenic organism, so virulence not relevant |
| Response to iron limitation | Likely affected due to altered mitochondrial function | Less adapted to iron-limited environments |
| Supercomplex formation | Complete prevention of supercomplex formation | Similar disruption pattern |
Interestingly, the S. pombe mIF3 can effectively complement a genomic disruption of S. cerevisiae AIM23, verifying that Aim23p functions as a bona fide mitochondrial translation initiation factor .
To create AIM23 deletion mutants in C. glabrata, researchers should follow a targeted gene deletion approach using homologous recombination. Based on established protocols for genetic manipulation of C. glabrata , the following methodology is recommended:
Primer Design:
Design primers that contain 500-1000 bp gene-specific flanking sequences homologous to regions upstream and downstream of AIM23
Include sequences for amplification of a selectable marker cassette (e.g., NAT1 for nourseothricin resistance)
Deletion Cassette Preparation:
Amplify the deletion cassette using PCR with the designed primers
Verify the cassette size and integrity by gel electrophoresis
Transformation:
Prepare electrocompetent C. glabrata cells at their logarithmic growth phase
Transform cells using electroporation (2.1 kV, 200 Ω, 25 μF) or a modified heat shock method (45°C for 15 min)
Plate on selective media containing the appropriate antibiotic
Verification:
Confirm successful deletion by PCR using primers binding outside the integration site
Verify the absence of AIM23 transcript by RT-PCR
Assess mitochondrial function through respiratory growth tests and cytochrome c oxidase activity measurements
When evaluating mitochondrial function in AIM23 mutant strains, a comprehensive approach involving multiple complementary techniques is advised:
Respiratory Capacity Assessment:
Compare growth rates on fermentable (e.g., glucose) versus non-fermentable (e.g., glycerol, ethanol) carbon sources
Monitor adaptation to respiratory growth conditions over time (6h, 24h, 48h, 72h)
Mitochondrial Membrane Potential Analysis:
Use fluorescent dyes such as Rhodamine 123 or DiOC6 followed by flow cytometry
Implement fluorescence microscopy to visualize membrane potential changes
Enzyme Activity Measurements:
Quantify cytochrome c oxidase activity in isolated mitochondria
Measure ATP synthase function
Mitochondrial Translation Analysis:
Perform pulse-labeling of mitochondrially synthesized proteins using [35S]methionine in the presence of cycloheximide
Analyze the translation products by SDS-PAGE and autoradiography
Respiratory Chain Complex Formation:
Assess the formation of respiratory chain supercomplexes using Blue Native PAGE
Evaluate complex assembly using specific antibodies
For complementation studies of AIM23 in C. glabrata, researchers should consider the following strategies:
Plasmid-Based Complementation:
Clone the wild-type C. glabrata AIM23 gene with its native promoter and terminator into a suitable shuttle vector
Consider using vectors with different selection markers than those used for the deletion
Transform the construct into the Δaim23 strain and select on appropriate media
Cross-Species Complementation:
Controlled Expression Systems:
Implement regulatable promoters (e.g., MET3, GAL1) to control the expression level
This allows assessment of dosage effects on the complementation efficiency
Domain Swap Experiments:
Create chimeric constructs with domains from mIF3 proteins of different species
These constructs can help identify critical functional regions
Verification of Complementation:
Assess restoration of cytochrome c oxidase activity
Evaluate growth on non-fermentable carbon sources
Measure mitochondrial membrane potential
Analyze the formation of respiratory chain supercomplexes
The relationship between AIM23 function and antifungal resistance is complex and likely involves several mechanisms:
Azole Resistance:
Echinocandin Susceptibility:
Changes in cell wall composition resulting from metabolic adaptations to mitochondrial dysfunction could potentially affect susceptibility to echinocandins
Alterations in FKS1/2 expression patterns might occur as compensatory mechanisms
Metabolic Adaptations:
AIM23 mutants likely undergo metabolic reprogramming to compensate for respiratory deficiencies
These adaptations may confer cross-resistance to multiple classes of antifungals
Energy-dependent drug efflux systems may be affected by the altered ATP production
Stress Response Activation:
Chronic mitochondrial stress in AIM23 mutants could pre-activate stress response pathways
This pre-activation might provide cross-protection against antifungal-induced stress
Mitochondrial heteroplasmy (the presence of multiple mitochondrial genotypes within a cell or population) could significantly impact AIM23 function in C. glabrata:
Heteroplasmic Dynamics:
Selection Pressures:
Mitochondrial DNA Diversity:
Evolutionary Implications:
Mitochondrial diversity combined with AIM23 variations could contribute to the remarkable adaptability of C. glabrata
This might explain how clinical isolates can rapidly adapt to different host environments and antifungal pressures
To effectively study AIM23-dependent mitochondrial translation in C. glabrata, researchers should employ a multi-faceted approach:
In organello Translation Assays:
Isolate intact mitochondria from wild-type and Δaim23 strains
Perform translation reactions with radiolabeled amino acids
Analyze translation products by SDS-PAGE and autoradiography
Compare patterns and intensities of newly synthesized mitochondrial proteins
Ribosome Profiling:
Apply ribosome profiling techniques specifically to mitochondrial ribosomes
Analyze the distribution of ribosomes on mitochondrial mRNAs
Identify specific translation initiation sites affected by AIM23 deletion
Protein-RNA Interaction Studies:
Perform RNA immunoprecipitation to identify mRNAs associated with AIM23
Use UV crosslinking to map precise interaction sites
Electrophoretic mobility shift assays to characterize binding affinities
Cryo-EM Structural Analysis:
Isolate mitochondrial ribosomes from wild-type and Δaim23 strains
Determine structural differences using cryo-electron microscopy
Identify how AIM23 interacts with the mitochondrial ribosome and initiation factors
Live-Cell Imaging:
Create fluorescently tagged versions of mitochondrial translation components
Track translation dynamics in real-time using high-resolution microscopy
Compare translation initiation rates between wild-type and mutant strains
To measure the impact of AIM23 on mitochondrial function during host infection, researchers should implement the following methodological approaches:
In vivo Infection Models:
Ex vivo Functional Assays:
Isolate C. glabrata from infected tissues and immediately assess mitochondrial function
Compare respiratory capacity, membrane potential, and ROS production
Analyze mitochondrial morphology using electron microscopy
Gene Expression Analysis:
Perform RNA-seq on C. glabrata cells recovered from infection sites
Compare expression profiles between wild-type and Δaim23 strains
Identify compensatory pathways activated in the absence of AIM23
Iron Limitation Response:
Macrophage Interaction Studies:
Co-culture C. glabrata with macrophages
Measure survival and proliferation within phagocytes
Assess mitochondrial function in cells exposed to the macrophage environment
To thoroughly analyze AIM23-dependent changes in the C. glabrata mitochondrial proteome, researchers should consider these methodological approaches:
Mitochondrial Isolation and Purification:
Use differential centrifugation combined with density gradient separation
Verify mitochondrial purity using marker proteins for different cellular compartments
Ensure minimal contamination from other organelles
Quantitative Proteomics:
Implement stable isotope labeling (SILAC) for precise quantification
Use label-free quantification as an alternative approach
Apply data-independent acquisition (DIA) for comprehensive proteome coverage
Targeted Analysis of Respiratory Complexes:
Blue Native PAGE to separate intact respiratory complexes
Second-dimension SDS-PAGE to identify subunit composition
Western blotting with specific antibodies against key components
Post-translational Modification Analysis:
Phosphoproteomics to identify changes in protein phosphorylation
Analysis of other modifications (acetylation, succinylation) relevant to mitochondrial function
Correlation of modification patterns with functional outcomes
Spatial Proteomics:
Submitochondrial fractionation to determine protein localization
Compare distribution between matrix, inner membrane, intermembrane space, and outer membrane
Identify proteins that show altered localization in the absence of AIM23
Integration with Functional Data:
Correlate proteomic changes with functional parameters
Connect specific protein alterations to observed phenotypes
Identify key nodes in the mitochondrial network affected by AIM23 deletion
The function of AIM23 across different Candida species likely shows both conservation and divergence, reflecting their evolutionary relationships and ecological niches:
Key comparative aspects include:
Sequence conservation and structural features of AIM23 proteins
Species-specific interactions with mitochondrial ribosomes
Differential importance in various carbon source environments
Varying contributions to virulence and stress resistance
Laboratory and clinical isolates of C. glabrata likely exhibit significant differences in AIM23-related phenotypes due to adaptation to different environments:
Genetic Background Variations:
Stress Response Differences:
Clinical isolates are adapted to host environments and stressors
They may show different compensatory mechanisms for mitochondrial dysfunction
Laboratory strains may exhibit more severe phenotypes upon AIM23 deletion
Drug Resistance Correlations:
Clinical isolates with specific mitochondrial haplotypes may show different relationships between AIM23 function and drug resistance
Laboratory-evolved resistance may involve different pathways than clinically-evolved resistance
Mitochondrial Heteroplasmy:
Clinical isolates may maintain different levels of mitochondrial heteroplasmy
This heteroplasmy could buffer against complete loss of AIM23 function
Laboratory strains might show more homogeneous mitochondrial populations
Experimental Evidence:
AIM23's role in mitochondrial function can be compared with other mitochondrial proteins known to affect C. glabrata virulence:
Targeting AIM23 for antifungal development presents several promising opportunities:
Selective Inhibition:
Design small molecules that specifically inhibit C. glabrata AIM23 function
Target unique structural features not present in human mitochondrial translation factors
Exploit differences in binding sites between fungal and human mIF3 proteins
Combination Therapy Approaches:
Use AIM23 inhibitors to sensitize C. glabrata to existing antifungals
Target both mitochondrial function and established antifungal mechanisms
Potentially overcome resistance mechanisms through multi-target approaches
Biomarker Development:
Identify AIM23 variants associated with drug resistance or enhanced virulence
Develop diagnostic tests to predict treatment outcomes
Guide personalized antifungal therapy based on AIM23 status
Screening Platforms:
Develop high-throughput screening systems using AIM23-dependent reporter strains
Screen natural product libraries for compounds that interfere with AIM23 function
Implement structure-based virtual screening based on AIM23 protein models
Challenges to Address:
Need for extreme selectivity to avoid human mitochondrial toxicity
Requirement for compounds that can access the fungal mitochondrial matrix
Potential for development of resistance through compensatory mechanisms
CRISPR-Cas9 technologies can be optimized for studying AIM23 function in C. glabrata through several approaches:
CRISPR-Cas9 Delivery Systems:
Develop efficient transformation protocols specific for C. glabrata
Optimize RNA polymerase III promoters for sgRNA expression
Engineer Cas9 variants with enhanced activity in C. glabrata
Precise Genetic Modifications:
Generate point mutations to study specific domains of AIM23
Create conditional knockdown systems using inducible promoters
Engineer epitope tags for protein visualization and purification
Multiplexed Editing:
Target AIM23 along with interacting partners
Create libraries of AIM23 variants to screen for functional domains
Simultaneously edit nuclear and mitochondrial genes affecting the same pathway
Regulatory Element Modification:
Edit AIM23 promoter regions to study expression regulation
Modify untranslated regions to analyze post-transcriptional control
Engineer stress-responsive elements to study regulation under various conditions
Technical Considerations:
Optimize homology-directed repair templates for maximum efficiency
Develop marker-free editing strategies
Implement CRISPR interference (CRISPRi) for transient repression studies
Advancing our understanding of AIM23's role in C. glabrata pathogenesis would benefit from these interdisciplinary approaches:
Systems Biology Integration:
Combine transcriptomics, proteomics, and metabolomics data
Build computational models of mitochondrial function in C. glabrata
Identify system-wide effects of AIM23 disruption
Structural Biology and Biophysics:
Determine the high-resolution structure of C. glabrata AIM23
Characterize interactions with the mitochondrial ribosome
Apply single-molecule techniques to study translation initiation dynamics
Host-Pathogen Interaction Studies:
Implement advanced imaging to visualize C. glabrata in host tissues
Develop organoid models to study infection in tissue-like environments
Analyze host immune responses to wild-type versus Δaim23 strains
Evolutionary and Comparative Genomics:
Analyze AIM23 conservation across pathogenic and non-pathogenic fungi
Study correlation between AIM23 variants and ecological niches
Examine how mitochondrial genome diversity affects AIM23 function
Clinical and Translational Research:
Correlate AIM23 variants in clinical isolates with patient outcomes
Develop diagnostic tools based on AIM23 function
Explore potential as a biomarker for drug resistance or virulence
These interdisciplinary approaches would provide a comprehensive understanding of AIM23's role in C. glabrata biology and pathogenesis, potentially leading to new therapeutic strategies against this important fungal pathogen.